Showing results (11-20 of 23) with videos related to
Sort By:
Pageof 3
Journal of Hepatocellular Carcinoma|March 21, 2023
LncRNA TGFB2-OT1 Promotes Progression and Angiogenesis in Hepatocellular Carcinoma by Dephosphorylating β-CateninYiran Chen, Xiaoling Wu, Xi Chen, et al.The Science of the Total Environment|June 17, 2023
Lactational retrorsine exposure changes maternal milk components and disturbs metabolism homeostasis of offspring ratsYongguo Dai, Qi Guo, Kequan Xu, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 22, 2026
OCTN2 Activates a Non-Canonical Carnitine Metabolic Pathway to Promote MASH-HCC Progression and Immunotherapy ResistanceChuqi Xia, Xiao Zhang, Jinze Li, et al.Cell Death & Disease|July 10, 2021
MYC-targeted WDR4 promotes proliferation, metastasis, and sorafenib resistance by inducing CCNB1 translation in hepatocellular carcinomaPeng Xia, Hao Zhang, Kequan Xu, et al.Cancer Communications (London, England)|January 5, 2023
METTL5 stabilizes c-Myc by facilitating USP5 translation to reprogram glucose metabolism and promote hepatocellular carcinoma progressionPeng Xia, Hao Zhang, Haofeng Lu, et al.Molecular Metabolism|July 7, 2022
A novel lncRNA RP11-386G11.10 reprograms lipid metabolism to promote hepatocellular carcinoma progressionKequan Xu, Peng Xia, Xiangdong Gongye, et al.Journal of Agricultural and Food Chemistry|March 9, 2021
Prenatal Exposure to Retrorsine Induces Developmental Toxicity and Hepatotoxicity of Fetal Rats in a Sex-Dependent Manner: The Role of Pregnane X Receptor ActivationYongguo Dai, Jinyuan Luo, E Xiang, et al.Cancer Letters|December 29, 2024
RNF5 exacerbates steatotic HCC by enhancing fatty acid oxidation via the improvement of CPT1A stabilityXi Chen, Yang-Wen-Qing Zhang, Hui Ren, et al.Nature Communications|June 21, 2026
Therapeutic targeting of AREL1 in hepatic stellate cells attenuates MASH-related liver fibrosisYang-Wen-Qing Zhang, Xiaoyu Pan, Minghe Zhang, et al.Hepatology (Baltimore, Md.)|September 7, 2023
LIM domain only 7 negatively controls nonalcoholic steatohepatitis in the setting of hyperlipidemiaTiangen Wu, Xi Chen, Kequan Xu, et al.Pageof 3